Dr. Lakshmi Chandra Mishra

Dr. Lakshmi C. Mishra is Director of National Center for Ayurveda and Toxicology Reviews, Rockville MD since April 2003. He provides education information about Ayurvedic health care. He is also working for CECON group of New York as a pharmacologist, toxicologist and research consultant to plan safety and efficacy studies and evaluate safety and efficacy clinical trial data on dietary supplements, drugs, and chemicals for US FDA and US EPA registration and labeling requirements.

Dr. Lakshmi C. Mishra was Adjunct Professor in the Research Division (1998-2003), provided clinical Ayurvedic services in the SCU health system; the first ayurvedic health care in the SCU clinic system. He has a long work history as a toxicologist for the federal government, has specialized in carcinogenesis and cancer chemotherapy research in the past (1974-1997), and has turned his attention to the development of treatment protocols combining Western Science and Ayurvedic principles. He provided the content expertise for the development and implementation of basic science, cancer chemotherapy and chemo-prevention using herbal dietary supplements. Dr. L.C. Mishra was PI of trials using animal models to investigate both guggul and another Ayurvedic herb, Ashwagandha.

He has an extensive background, both as a clinician in modern and Ayurvedic medicine and as a bench scientist in cancer chemotherapy, pharmacology and toxicology, a unique combination of qualifications indeed. He has been a reviewer for Alternative Therapies in Health and Medicine (ATHM) particularly in the areas of cancer chemotherapy, pharmacology, toxicology, Ayurvedic herbal therapies. He was an advisor to RAND Corporation (2000-01), Los Angeles, California for a systematic review of Ayurvedic therapies for a specific diagnosis, funded by AHRQ, P.I., Ian Coulter. He was also a member of the editorial board for Journal of American Nutraceutical Association till Spring 2002. His other interest includes osteoarthritis and autoimmune diseases, e.g., rheumatoid arthritis. He has collaborated with the University of Southern California, School of Pharmacy to study the effects of Guggul and Ashwagandha in protecting oxidative DNA fragmentation in rat brain in a stroke rat model.

For more information visit: www.lcmishra.com.